No abstract available.
Intracranial Hemorrhages* ; Stroke*

No abstract available.
Hemorrhage* ; Intracranial Hemorrhages*

No abstract available.
Intracranial Hemorrhages* ; Thrombolytic Therapy*

This study carried out on 72 patients with secondary cerebroventricular hemorrhage and 115 patients with cerebral hemorrhage, without cerebroventricular apoplexy. The results showed that the cerebral hemorrhage in any area could lead to secondary cerebroventricular apoplexy. 65% of cases with thalamic hemorrhage had cerebroventricular apoplexy. The dimension of blood clot in the secondary cerebroventricular hemorrhage was larger than this in the cerebro parenchyma hemorrhage without apoplexy. The clinical characteristics included sudden crisis, conscious disorder, and cerebral stimulation. The mortality rate was 25%.
Intracranial Hemorrhages ; diagnosis

No abstract available.
Gestational Age* ; Intracranial Hemorrhages*

Background: Intracranial hemorrhage (lCH) is a common disease with high rate of mortality and neurological sequel. Objectives:to estimate preventive effectiveness of intracranial hemorrhage by vitamin K1 and K3 for newborns just after birth". Subjects and methods: An epidemiological, randomized control study with intervention was conducted. The study included all children under 3 months with and without ICH during period 1/1/2000 -30/6/2004 living in Hatay province. Among them all the newborns during period 1/6/2002 - 30/6/2004 were injected either 1 mg vitamin K1 or K3. Results: Children injected with vitamin K in the intervention period were followed up in three months and evaluated by a united process. Effects of intervention were calculated by preventive value. 62.057/82069 newborns were injected vitamin K1 or Vitamin K3 (25.725 newborns were injected Vitamin K1; 36.332 newborns were injected vitamin K3). Single dose 1M reduced the rate of ICH in infants: The morbidity changed from 3.3\ufffd?to 0.82\ufffd? the prevention value was 96%. There were no complications and side effects of vitamin K injections reported. Conclusions: Injection of vitamin K1 and K3 have similar preventive effectiveness. Vitamin K injection 1M with recommended dose was safe for newborns.\r\n', u' \r\n', u'\r\n', u'
Intracranial Hemorrhages ; Vitamin K Deficiency

A male patient aged 52 was admitted due to an attack to manage the hypertensive intracerebral hematoma at the left subfrontal region. An operation of supraorbital keyhole approach via a superciliary skin incision was performed. Result showed a shortened surgical time of a minimal invasion, almost hematoma was removed completely. Post-operative status was stable and the patient was discharged with GOC score of 5
Intracranial Hemorrhage, Hypertensive ; Intracranial Hemorrhages ; surgery ; Therapeutics

Study on 86 patients with intraventricular hemorrhage among 201 hemorrhagic stroke patients treated at Central Military Hospital 108, Friendship Hospital, and Hospital No 103. Results: in primary intraventricular hemorrhage: 85.7% of patients had hemorrhage in whole cerebroventricular system; severity: severe: 50%, moderate: 28.6%, mild: 21.4%; 64.3% patients suffered from complication of cerebroventricular dilatation. In secondary intraventricular hemorrhage: 23.6% of patients had hemorrhage in whole cerebroventricular system, 34.7% patients with unilateral hemorrhage and 26.4% patients with bilateral hemorrhage; severity: severe: 59.7%, moderate: 31.9%, and mild: 8.3%; 48.6% patients had complication of cerebroventricular dilatation. This complication occurred in 53.8% patients with thalamus hemorrhage, 41.9% patients with hemorrhage of corpus striatum-interior capsule, and 37.5% patients with lobar hemorrhage. 13.9% patients had hematoma volume more than 60cm3 and 17.7% of hematomas caused grade III of space-occupying hematoma.
Intracranial Hemorrhages ; Tomography, X-Ray Computed

Background:Cerebral vasospasm is a proved reaction and nimodipin revolutionised the treatment of subarrachnoid hemorrhage in adult. However, the effectiveness of Nimodipin in cerebral vasospasm remained controversial in intracranial hemorrhage (lCH) in children. Objectives:This study aims to estimate the effectiveness of nimodipin in treatment of children with intracranial hemorrhage.Subjects and method:A descriptive, prospective study was conducted on all children patients diagnosed intracranial hemorrhage and treated at Neurology department of National Hospital for Pediatric, Vietnam from 2004 to June 2007. They applied the Transcranial Doppler sonography (TCD) in diagnosis of vasospasm in intracranial hemorrhage in children and follow-up the evolution after treatment with nimodipin. Results:The results showed that cerebral vasospasm with hight resistance index (RI) on TCD (RI = 0.78 \xb1 0.08) and cerebral ischemie with low systolic velocity (Vs = 68 \xb1 12.2 crn/s) and hight pulsality index (PI = 1.4 \xb1 0.13) were observed in 100% of cases after 3 days with ICH. Nimodipine improved clinical status (71.2%) and CT scan (52%), also RI, PI, Vs returned to normal when used nimodipin within 7 days of ICH. Conclusion: The treatment method for intracranial hemorrhage with nimodipin supplement had proved to have initial effecacy in comparison with traditional method.
Intracranial Hemorrhages/ therapy ; Nimodipine/ therapeutic use ; Infant

Background: Intracranial haemorrhage is a common emergency with high mortality and neurological sequelae Objectives: The aim of study were to estimate the distribution of intracranial haemorrhage between the groups of age in children and the relationship of epidemiologic characteristics to the etiology.Subjects and method: We gathered prospectively data on 621 children (0-15 ans of age) with intracranial haemorrhage in 3 years (2000, 2001, 2002) hospital records in the National Hospital Pediatrics. Results: There are annual 200 patients (0-15 ans of age) of administration. 1) Neonatal infants consisted of 97 (15,6%) patients and 35 (36,1%) of death. Some of epidemiologic characteristics associated with the etiology were premature, asphyxial over 3500 gram birth weight, interventional birth infants and infants with congenital and acquis coagulation disorders. 2) Breastfed infants consisted of 469 (75,5%) patients of administration and 52 (11,1%) of death. Infants at 29 days to 3 months of age were the most frequence (92,3%). The etiology was associated with coagulation disorders (82,9%), cholestasis (6,2%). 3)Children (1-15ans) consisted of 55 (8,9%) and 7,3% of death, specially adolescent children (7-15ans) occupied 86,3% patients in this group. The etiology could be cerebral vasculare malfmation. Conclusion: There are different distribution of administration, mortality, etiology between neonate, breastfed infants, children (1-15 ans of age)
Intracranial Hemorrhages/ epidemiology ; Child ; Infant ; Infant ; Newborn ;